Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Immunotherapy of sarcomas.

Goldberg JM.

Curr Opin Oncol. 2013 Jul;25(4):390-7. doi: 10.1097/CCO.0b013e3283622c8a. Review.

PMID:
23736878
2.

Future directions for immunotherapeutic intervention against sarcomas.

Maki RG.

Curr Opin Oncol. 2006 Jul;18(4):363-8. Review.

PMID:
16721132
3.

Immunotherapy in sarcoma: a new frontier.

Wilky BA, Goldberg JM.

Discov Med. 2014 Apr;17(94):201-6. Review.

4.

From vision to reality: deploying the immune system for treatment of sarcoma.

Wilky BA, Goldberg JM.

Discov Med. 2017 Jan;23(124):61-74. Review.

5.

Dendritic cell immunotherapy in soft tissue sarcoma.

Indelicato DJ, Finkelstein SE.

Immunotherapy. 2012 Oct;4(10):1023-9. doi: 10.2217/imt.12.106. Review.

PMID:
23148754
6.

Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away.

Lee A, Huang P, DeMatteo RP, Pollack SM.

Am Soc Clin Oncol Educ Book. 2016;35:281-90. doi: 10.14694/EDBK_157439.

7.
8.

Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities.

Yu Z, Ren P, Zhang X, Zhang T, Ma B.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1065-71. doi: 10.1586/era.09.78. Review.

PMID:
19671026
9.

Soft tissue sarcoma as a model disease to examine cancer immunotherapy.

Maki RG.

Curr Opin Oncol. 2001 Jul;13(4):270-4. Review.

PMID:
11429485
10.

Sarcomas and the immune system: implications for therapeutic strategies.

Francescutti V, Skitzki JJ.

Surg Oncol Clin N Am. 2012 Apr;21(2):341-55. doi: 10.1016/j.soc.2011.11.002. Epub 2011 Dec 16. Review.

PMID:
22365524
11.

Immunotherapeutic approaches to sarcoma.

Burgess M, Tawbi H.

Curr Treat Options Oncol. 2015 Jun;16(6):26. doi: 10.1007/s11864-015-0345-5. Review.

PMID:
25975445
12.

Prostate cancer immunotherapy.

McNeel DG.

Curr Opin Urol. 2007 May;17(3):175-81. Review.

PMID:
17414515
13.

Immunotherapeutic approaches to sarcoma.

Linehan DC, Bowne WB, Lewis JJ.

Semin Surg Oncol. 1999 Jul-Aug;17(1):72-7. Review.

PMID:
10402640
14.

New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.

Lim J, Poulin NM, Nielsen TO.

Clin Cancer Res. 2015 Nov 1;21(21):4753-9. doi: 10.1158/1078-0432.CCR-15-0831. Epub 2015 Sep 1. Review.

15.

New molecular targets and biological therapies in sarcomas.

Scappaticci FA, Marina N.

Cancer Treat Rev. 2001 Dec;27(6):317-26. Review.

PMID:
11908925
16.

Adult human sarcomas. II. Medical oncology.

Sinkovics JG.

Expert Rev Anticancer Ther. 2007 Feb;7(2):183-210. Review.

PMID:
17288529
17.

Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?

Kamrava M, Bernstein MB, Camphausen K, Hodge JW.

Mol Biosyst. 2009 Nov;5(11):1262-70. doi: 10.1039/b911313b. Epub 2009 Aug 27. Review.

PMID:
19823740
18.

[New directions in immunotherapy for malignant solid tumors].

Okuno K, Sugiura F, Sukegawa Y, Inoue K.

Nihon Rinsho. 2012 Dec;70(12):2075-86. Review. Japanese.

PMID:
23259377
19.

Immunity against soft-tissue sarcomas.

Maki RG.

Curr Oncol Rep. 2003 Jul;5(4):282-7. Review.

PMID:
12781069
20.

Immune Therapy for Sarcomas.

Anderson PM.

Adv Exp Med Biol. 2017;995:127-140. doi: 10.1007/978-3-319-53156-4_6. Review.

PMID:
28321815

Supplemental Content

Support Center